Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 7, 2001

View Archived Issues

Protherics Gains U.S. Approval Of CroFab, Raises £3.1M Privately

Growth Factor Discoveries Point To New Approach For Metastasis

Analytica Capitalizes On Taiwan Initiative Through New Subsidiary

Co.don Taking Cell Platform Public On Market In Germany

Bavarian Nordic Licenses Vaccine Technology From Australian Firm

Ethics Expert Describes EU Biotechnology 'Culture Shock'

GeneScan, Motorola Developing Device For On-Site DNA Analysis

SR Pharma, YM Biosciences Combine Products For Trial

Monitor Report Advises Israel To Take Initiatives In Biotech

Molecular Templates Taking Aim At Cancer Therapeutics

Novagali Sets Up Ginoptle Shop To Focus On Delivery Technology

Other News To Note

BioMérieux, Celera Collaborate On Improving Cancer Therapies

Parliament Committee Urges Caution In EU Biotech Industry

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...